نتایج جستجو برای: refractory hypertension
تعداد نتایج: 210043 فیلتر نتایج به سال:
BACKGROUND The prevalence of portopulmonary hypertension (PPHTN) in patients with cirrhosis and refractory ascites is unknown. Its presence may preclude patients from receiving a transjugular intrahepatic portosystemic shunt or liver transplantation as a definitive treatment for their end stage cirrhosis. PURPOSE To determine the prevalence, possible aetiological factors, and predictive facto...
BACKGROUND Agonistic autoantibodies directed at the alpha(1)-adrenergic receptor (alpha(1)-AAB) have been described in patients with hypertension. We implied earlier that alpha(1)-AAB might have a mechanistic role and could represent a therapeutic target. METHODOLOGY/PRINCIPAL FINDINGS To pursue the issue, we performed clinical and basic studies. We observed that 41 of 81 patients with refrac...
Thalidomide is an effective treatment both in advanced multiple myeloma (MM) and as first-line therapy in combination with dexamethasone or other cytotoxic chemotherapy [1, 2]. Two cases [3, 4] of pulmonary hypertension in the absence of thromboembolic events have been described in patients with MM during thalidomide treatment [5]. A 63-year-old woman was diagnosed in 1998 with IIA MM IgG kappa...
OBJECTIVES The aim of this prospective randomized study was to assess the impact of renal artery denervation in patients with a history of refractory atrial fibrillation (AF) and drug-resistant hypertension who were referred for pulmonary vein isolation (PVI). BACKGROUND Hypertension is the most common cardiovascular condition responsible for the development and maintenance of AF. Treating dr...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید